Advanced technologies for molecular diagnosis of cancer: State of pre-clinical tumor-derived exosome liquid biopsies

Exosomes are membrane-defined extracellular vesicles (EVs) approximately 40-160 nm in diameter that are found in all body fluids including blood, urine, and saliva. They act as important vehicles for intercellular communication between both local and distant cells and can serve as circulating biomarkers for disease diagnosis and prognosis. Exosomes play a key role in tumor metastasis, are abundant in biofluids, and stabilize biomarkers they carry, and thus can improve cancer detection, treatment monitoring, and cancer staging/prognosis. Despite their clinical potential, lack of sensitive/specific biomarkers and sensitive isolation/enrichment and analytical technologies has posed a barrier to clinical translation of exosomes. This review presents a critical overview of technologies now being used to detect tumor-derived exosome (TDE) biomarkers in clinical specimens that have potential for clinical translation.

Automated summary

Exosomes are membrane-defined extracellular vesicles (EVs) that act as important vehicles for intercellular communication and can serve as circulating biomarkers for disease diagnosis and prognosis. They play a key role in tumor metastasis, are abundant in biofluids, and stabilize the biomarkers they carry, thus improving cancer detection, treatment monitoring, and cancer staging/prognosis. However, the lack of sensitive/specific biomarkers and isolation/enrichment technologies has hindered the clinical translation of exosomes.